The just-released clinical trial results revealed that high-dose immunosuppressive therapy when followed closely by a transplant of a person blood-forming stem cells could lead to continued remission of multiple sclerosis. The MS is an autoimmune disease, which attacks the nervous system of the immune. Research shows that over a trial period of five years of receiving high-dose immunosuppressive therapy, high dose treatment combined with autologous hematopoietic cell transplant, some patients survived without experiencing brain issues, any progression of disability, or release of MS symptoms. Scientists have also discovered that other MS drugs that are currently being issued have minimal success rates. The National Institute of Allergy and Infectious Disease was the primary sponsor of the trial period, and three-year results were published where more extended findings are expected to be released by neurologists as time goes.
Shiva Vasishta is a neurologist in New Jersey who has over forty years of experience in the medical field and is affiliated with the Kennedy University Hospital. Dr. Shiva Vasishta studied in a governmental institution, Nagpur Government Medical College, where he received his medical degree in 1979 and has been in practice since then. He has qualified to be listed among the thirty-four doctors who specialize in Neurology in Kennedy University Hospital.Shiva GopalVasishta is the current Managing Director of Voorhees NJ, and he also specializes in Psychiatry. Having completed his residency at Boston City Hospital and left a legacy, he is now placed at Eastern Neurodiagnostic Associates and participates in Cherry Hill Campus medical department operations. Dr. Shiva Vasishta is known to accept various insurance plans which include, Aetna Medicare, the Blue Shield. He is a certified neurologist by the Medical Board, and he can practice in the English and French language with ease.Dedication, commitment, and discipline are the core values that guide Shiva Vasishta in his career.